Author:
Hu Tong,Li Yi-Han,Han Wen-Qiang,Maduray Kellina,Chen Tong-Shuai,Hao Li,Zhong Jing-Quan
Funder
National Natural Science Foundation of China
Qingdao Key Health Discipline Development Fund
Qingdao Key Clinical Specialty Elite Discipline
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine
Reference43 articles.
1. Castillero E, Akashi H, Pendrak K, Yerebakan H, Najjar M, Wang C, et al. Attenuation of the unfolded protein response and endoplasmic reticulum stress after mechanical unloading in dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2015;309(3):H459–70.
2. Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;120(9):1501–17.
3. Cairns JA. ACP journal club. CHA2DS2-VASc had better discrimination than CHADS2 for predicting risk for thromboembolism in atrial fibrillation. Ann Intern Med. 2011;154(10):JC5-J13.
4. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857–67.
5. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, et al. Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC working group on thrombosis—task force on anticoagulants in heart disease. Thromb Haemost. 2013;110(6):1087–107.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献